SNAP‑8 — Overview

SNAP‑8 (Acetyl Octapeptide‑3) is a synthetic octapeptide developed as an extended analog of Argireline, designed to modulate the SNARE complex involved in neurotransmitter release. It is widely studied in cosmetic biochemistry for its role in expression line reduction and neuromuscular signaling modulation.

Research consistently describes it as a topical, non‑invasive alternative to more aggressive neuromodulators, acting by reducing the mechanical intensity of facial muscle contractions.

Mechanism of Action

SNAP‑8 works by:

• Mimicking the N‑terminal of SNAP‑25, a key SNARE protein
• Competitively inhibiting SNARE complex formation
• Reducing acetylcholine release at neuromuscular junctions
• Lowering muscle contraction intensity, which decreases expression line formation

This mechanism is well‑documented in peptide research and cosmetic science literature.

Key Research Characteristics

• Peptide Type: Synthetic octapeptide
• Origin: Developed by Lipotec (2006)
• Primary Use Case: Anti‑wrinkle and expression line research
• Molecular Weight: ~1,075 Da
• Activity: Neuromuscular signaling modulation
• Application Context: Topical formulations in cosmetic research

Studies report up to 63% wrinkle depth reduction in certain clinical models, highlighting its relevance in dermatological peptide research.

Research Applications

SNAP‑8 is commonly examined in:

• Dermatology and anti‑aging research
• Neuromuscular signaling studies
• Comparative models vs. Argireline or botulinum‑toxin‑like mechanisms
• Topical peptide delivery systems
• Expression line formation pathways

Its ability to modulate neurotransmitter release makes it a valuable model peptide for studying non‑paralytic neuromodulation.

Form & Handling

• Form: Lyophilized powder
• Solubility: Reconstituted in sterile, research‑grade solvents
• Storage: Cool, dry environment; protect from light
• Purity: Typically ≥99% for laboratory use

For laboratory research only. Not for human consumption.